In addition, in CLL patients, the expansion of CD16+ monocytes correlates with the rate of bone erosion [8], thus suggesting that these cells are more prone to differentiate toward osteoclasts. The gene discussed is FCGR3A; the disease is B-cell chronic lymphocytic leukemia.